Brief: Inify Laboratories Q4 EBITDA Loss SEK 13,1 Mln
26/02/2025 07:06
Feb 26 (Reuters) - INIFY Laboratories AB INIFY.OL: Q4 – NET REVENUES OF 4.8 MSEK Q4 EBITDA LOSS SEK 13,1 MILLION Source text: ID:nWkrbJKtvZ Further company coverage: INIFY.OL (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on INIFY Laboratories AB
See all newsBrief: Inify Laboratories Signs Deal With University Hospitals Plymouth NHS Trust
Brief: Inify Laboratories Gets CQC Registration, Is Fully Operational In UK
Brief: Inify Laboratories Q1 Sales Up At SEK 6.3 Mln
Brief: Inify Laboratories Signs Agreement With Region Jämtland Härjedalen
Brief: Inify Laboratories Has Signed An Agreement With Region Jamtland Harjedalen For Prostate Cancer Diagnostics